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Abstract A 19 kDa protein was identified in specific granules 
of human neutrophils. A full-length cDNA clone was isolated 
from a human CML cDNA library, based on amino-acid se- 
quences of isolated tryptic fragments. This clone includes the 
recently identified cDNA for FALL-391CAP-18. Aminoacid se- 
quences of proteolytic fragments derived both from the conserved 
N-terminal cathelin-like region and the highly variable C-termi- 
nal region characteristic of this family of bactericidal, LPS bind- 
ing proteins, were in complete agreement with the sequence de- 
duced from the cDNA. Thus, the 19 kDa protein is hCAP-18, 
stored as a 'pro-peptide' in specific granules. 
2. Materials and methods 
2.1. Subcellular fractionation 
Human neutrophils were isolated from freshly drawn blood and 
disrupted by nitrogen cavitation following treatment with 5 mM DFP 
(Aldrich) [6]. The post-nuclear supernatant (10 ml), was loaded on a 
3-layer Percoll (Pharmacia) density gradient (gradient volume 27 ml) 
and fractionated [5]. Azurophil granules were identified by their content 
of myeloperoxidase [7], specific granules by lactoferrin [7], gelatinase 
granules by gelatinase [5,8], and plasma membranes by HLA, all as- 
sayed by ELISA [5,9,10]. Secretory vesicles were identified by their 
content of latent alkaline phosphatase [4], assayed as described [11] and 
by their content of albumin, assayed by ELISA [12]. 
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1. Introduction 
The neutrophilic granulocyte is the main mobile phagocyte, 
essential in the primary defense against intruding microorgan- 
isms. Intracellular granules are important as stores of bacteri- 
cidal substances that are liberated to the phagocytic vacuole 
during phagocytosis. In addition, the granule membrane con- 
tains proteins that serve important functions during adhesion, 
diapedesis and phagocytosis when these proteins are translo- 
cated to the plasma membrane and the phagosomal membrane 
[1]. Several subsets of granules have been identified in addition 
to the highly mobilizable secretory vesicles[2~]. In order to 
systematically investigate the content of these different granule 
subsets, and in particular to identify novel proteins, human 
neutrophils were disrupted and fractionated on a 3-layer Per- 
coil density gradient [5]. Isolated azurophil granules, specific 
granules, gelatinase granules, and light membranes (secretory 
vesicles and plasma membranes), were subjected to Triton X- 
114 phase separation and the protein profiles of the hydropho- 
bic and hydrophilic phases investigated by SDS-PAGE. An 
unidentified 19 kDa band, that partitioned exclusively in the 
Triton X-114 rich phase of specific granules, was observed. 
2.2. Identification of hCAP-18 
Fractions corresponding to peak values of azurophil granules (~- 
band), specific granules (fl:band), gelatinase granules (fl2-band), and 
secretory vesicles and plasma membranes (T-band), respectively [5], 
were pooled and Percoll removed by centrifugation [6]. The biological 
material was resuspended in relaxation buffer [6], and Triton X-114 was 
added to a concentration of 0.7%. Phase separation was then carried 
out as described by Bordier [13], and SDS-PAGE was performed on a 
5 20% polyacrylamide gradient [14]. Proteins were electroblotted to
ProBlott membranes (Applied Biosystems) in 10% (v/v) methanol, 10 
mM CAPS buffer, pH 11, and stained with 0.1% Coomassie blue or 
Amido black. The 19 kDa band was cut out, and the piece of membrane 
cut into smaller pieces and washed once with 50% methanol followed 
by buffer. Then the protein was incubated overnight at 37°C with either 
0.5 ~tg trypsin or 0.28/lg endoproteinase Asp-N (both sequence grade, 
Boehringer-Mannheim), including 0.1% reduced Triton X- 100 and 10% 
acetonitrile in the buffer as suggested for trypsin [15], which also 
worked for endoproteinase Asp-N. Following incubation, the samples 
were sonicated for 5 min, centrifuged, and the supernatant collected. 
This was repeated with buffer and 0.1% and 10% TFA. The peptides 
in the combined supernatants were separated by reverse phase HPLC 
employing a Vydac C8 column (2.1 × 150 mm) eluted with a gradient 
from 0.1% TFA water to 0.1% TFA in acetonitrile. The fragments were 
identified by mass spectrometry and sequence analysis. Laser desorp- 
tion mass spectrometry was performed in a Biflex instrument (Bruker- 
Franzen) using ~-cyano-4-hydroxycinnamic cid as matrix. Sequence 
analyses were performed on a Protein Sequencer model 475 A, 
equipped with on-line HPLC detection or a Procise Protein Sequencer, 
both from Applied Biosystems). For cleavage with CNBr, the central 
part of the 19 kDa band was cut to fit the slot in the blot cartridge of 
the Procise sequencer. Ten/11 of CNBr in 50% TFA (50 g/l) was added. 
The blot was incubated overnight at room temperature in the dark in 
a argon-atmosphere in aclosed 50 ml tube containing 2 ml of 50% TFA 
in the bottom, dried and subjected to sequence analysis. 
*Corresponding author. Fax: (45) (3) 545-4841. 
Abbreviations: bp, base pair; CML, chronic myeloid leukemia; DFP, 
diisopropyl fluorophosphate; ELISA, enzyme linked immunosorbent 
assay; HLA, human leukocyte antigen; LPS, lipo-polysaccharide; SDS- 
PAGE, sodium dodecyl sulphate polyacrylamide gel electrophoresis; 
PCR, polymerase chain-reaction; TFA, trifluoroacetic acid. 
2.3. Cloning of hCAP-18 
On the basis of the amino-acid sequence of tryptic fragments, a
degenerate primer CAGCAGCCICCIGA(AG)GA(CT)TG(CT)GA- 
(CT)T was used along with a library specific primer for PCR amplifica- 
tion from a human CML cDNA library [16]. An approximately 450 bp 
PCR product was subcloned into the phagemid vector pBluescript II
KS + (Stratagene). Two clones of the 3'-region were sequenced. The 
largest contained the last 279 bp of hCAP-18 and part of the poly(A) 
tail. The other clone terminated 19 bp upstream of the poly(A) site. 
Based on the nucleotide sequence, a specific primer CCCCTGGCCT- 
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GGTTGAGG was made and used against a library specific primer for 
PCR amplification from the cDNA library. A PCR product of approx- 
imately 750 bp was cloned in the plasmid vector pCR II using the TA 
cloning kit (Invitrogen). Two clones were sequenced and found to 
contain the 5'-end of hCAP-18. The largest clone included 35 bp of the 
5'-non-translated r gion, the shortest clone terminated atthe G of the 
start codon. 
3. Results and discussion 
The protein profiles of the isolated subcellular f actions how 
marked differences between azurophil granules, specific gran- 
ules, gelatinase granules, and plasma membranes and secretory 
vesicles (Fig. 1). These differences relate both to proteins parti- 
tioning into the Triton-rich, hydrophobic phase, and to the 
Triton-poor, hydrophilic phase. 
One of the dominating bands in specific granules is a 19 kDa 
protein, provisionally termed p19, that partitioned exclusively 
in the Triton X-114 rich phase. We sought to identify this 
protein by amino acid sequence analysis of intact electroblotted 
protein and of tryptic fragments generated by digestion of the 
protein after transfer to ProBlott membranes. We were unable 
to obtain the N-terminal sequence of the undigested protein, 
indicating that it is N-terminally blocked. However, the follow- 
ing internal sequences of tryptic peptides, given in one-letter 
codes, were identified: Fragment 1." AIDGINQR;  Fragment 2: 
SSDANLYR; Fragment 3: LLDLDPRPXMD. A fourth frag- 
ment gave a double sequence in the first 6 residues followed by 
a single sequence for another 6 cycles. By alignment with the 
later cDNA deduced sequence, this fragment could be identi- 
fied as two peptides: 4A ETVXPR, and 4B TTQQSPEDXD- 
FK, linked by a disulfide bridge between C in the two X posi- 
tions. The measured molecular mass is in accordance with this 
structure. A search in the EMBL database showed a high de- 
gree of homology to the pro-bactenecin family of bovine neu- 
trophil proteins, but gave no hits on known human proteins. 
Bactenecins were originally identified as small highly bacteri- 
cidal peptides known as Bac 7 (7 kDa) and Bac 5 (5 kDa)[17], 
and cyclic dodecapeptide [18], all with little amino acid se- 
quence similarity. These peptides were later shown to be stored 
as 15 20 kDa 'pro-peptides' in a specialized granule subset of 
bovine neutrophils called large granules [19]. The proteins are 
all highly homologous in their 'pro-peptide' region to cathelin, 
a protein initially identified in porcine neutrophils as an inhib- 
itor of cathepsin L [20]. This activity was later shown to reside 
in a contaminating protein [21]. PCR cloning of mRNA from 
porcine bone marrow has revealed that cathelin most likely is 
a processing product of a 'pro-peptide' of similar composition 
as the 15 20 kDa proteins of bovine neutrophils [22 24]. In 
rabbits, 3 members of the same family of proteins have been 
identified, CAP-18 [25], and two pl5's [26]. While the bacteri- 
cidal effects of these proteins have only been demonstrated for 
the C-terminal peptides generated through proteolytic leavage 
(as effectuated by elastase, a protein of azurophil granules) [27], 
the holo-peptides are able to bind and inactivate LPS, as dem- 
onstrated by CAP-18 [28]. 
To further characterize p 19, cDNA amplification of a human 
myeloid (CML) cDNA library was performed by PCR, using 
library specific primers and degenerate primers designed on the 
basis of the amino acid sequence of the tryptic fragments iden- 
tified. The cDNA sequence is given in Fig. 2 along with the 
deduced amino acid sequence of the protein. The cDNA se- 
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Fig. 1. Subcellular fractionation and SDS-PAGE profile of human 
neutrophil granules. (A) 7 x 10 8 neutrophils were fractionated on a 
3-layer Percoll density gradient and fractions of 1.0 ml collected and 
analyzed. Distribution of myeloperoxidase (I), lactoferrin (*), gelati- 
nase (A), latent alkaline phosphatase (g), Albumin (e), and HLA (v) 
is given and expressed as % of total. Fractions were pooled as indicated 
by a, fl~, f12, and y. (B) The ~ (azurophil granules), fll (specific granules), 
f12 (gelatinase granules) and )' (secretory vesicles and plasma mem- 
branes) bands were each resuspended to 1.1 ml and subjected to Triton 
X-114 phase separation. The Triton micelles collected were resus- 
pended to the original volume. Seventy-five/21 of the material before 
phase separation (total), of the Triton X-114 supernatant (hydrophilic), 
and of the Triton X-114 pellets (hydrophobic) were run on a 5-20% 
polyacrylamide g l under reducing conditions: Lanes: 1 -- MW-std; 
2 = ~(total); 3 = c~(hydrophilic); 4 = a(hydrophobic); 5= ill(total); 
6 = flL(hydrophilic); 7= fl~(hydrophobic); 8 = f12 (total); 9 = fl2(bydro- 
philic); 10 =flz(hydrophobic); 11 = 7(total); 12 = y(hydrophilie); 
13 = 7(hydrophobic); 14 = MW-std. p19 is indicated by triangle. 
quence includes two sequences recently cloned from human 
bone marrow cDNA libraries on the basis of similarity with 
cDNA of porcine PR-39 and rabbit CAP-18, respectively 
[29,30]. One has been termed FALL-39 based on the assump- 
tion that this cDNA codes for a pre-pro-peptide that would 
result in a 39 amino acid peptide starting with the aminoacids 
FALL after full processing. However, no translation or proc- 
essing product corresponding to this cDNA was demonstrated. 
Larrick et al. [30] showed that polyclonal antibodies generated 
against recombinant human CAP-18 protein reacted with an 18 
kDa and a 14 kDa protein of human neutrophils, the latter 
presumed to be the N-terminal part of the 18 kDa protein, and 
representing the cathelin-like sequence that is highly conserved 
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CGAA TTCGGCACGAGGT~JC~TAGAGGGAGGCAGACATGGGAACC (-1) 
ATG AAG ACC CAP,. AGG GAT GGC CAC TCC CTG GGG CGG TGG TCA CTG (45) 
M K T Q R D G H S L G R W S L (15) 
GTG CTC CTG CTG CTG GGC CTG GTG ATG CCT CTG GCC ATC A'I'£ GCC (90) 
V L L L L G L V M P L A I I A (30) 
CAG GTC CTC AGC TAC AAG GAA GCT GTG CTT CGT GCT ATA GAT GGC (135) 
FQ V L S Y K E A V L R [A I D G (45) 
ATC AAC CAG CGG TCC TCG GAT GCT AAC CTC TAC CGC CTC CTG GAC (180) 
1 N Q R] |S S D A N L Y R] [L L D (60) 
CTG GAC CCC ACrG CCC ACG ATG GAT GGG GAC CCA GAC ACG CCA AAG (225) 
L D P R P T M {D] G D P D T P K (75) 
CCT GTG AGC TTC ACA GTG AAG GAG ACA GTG TGC CCC AGG ACG ACA (270) 
P V S F T V K [E T V C P R] IT T (90) 
CAG CAG VCA CCA GAG GAT TGT GAC TIC AAG bAG GAC GC~ CTG GTG (315) 
Q O S P El D C D F K l K D G L V (105) 
AAG CGG TGT ATG GGG ACA GTG ACC CTC AAC CAG GCC AGG C_JC~ TCC (360) 
K R C M {G T V T L N Q A R G S (120) 
TTT GAC ATC AGT TGT GAT AAG GAT AAC AAG AGA TIT GCC CTG CTG (405) 
V O 1 S C O K D N K R F A L L (135) 
GGT GAT Trc  TTC CGG AAA TCT AAA GAG AAG ATT GGC AAA GAG TYI' (450) 
G D F F R K S K E K I G K E F (150) 
AAA AGA ATT GTC CAG AGA ATC AAG GAT TIT TFG CGG AAT CTT GTA (495) 
K R} l V Q R I K D F L R N L V (165) 
CCC AGG ACA GAG TCC TAG TGTGTGCCCTACCCTGCJCTCAGGCTI'CT~JGCFCTG 
P R T E S (170) OVIW 19301) 
AGAAATAAACTATGAGAGCAATrTCAAAAAAAAAAAAAAAAAAAAAAAAA(599) 
Fig. 2. cDNA and amino acid sequence of hCAP-18. The cDNA se- 
quence isgiven as determined from clones with overlapping sequences. 
The initial 10 bases in italics are library specific. The localization of 
sense and antisense primers for PCR amplification is underlined. The 
deduced amino acid sequence is given. The amino acids identified by 
protein sequence analysis are given in boldface and the fragments indi- 
cated by [] for trypsin, and { } for CNBr. r indicates N-terminal of 
mature protein 
among the members of this family. It is therefore possible that 
the antibody may have recognized other members of the cathe- 
lin-family than the protein whose cDNA was cloned and 
termed CAP- 18. 
To verify that the cloned cDNA corresponds to the p19 
protein, and to further characterize this, the protein was di- 
gested with endoproteinase Asp-N and CNBr. Digestion with 
endoproteinase Asp-N gave rise to several fragments, two of 
which gave no signal by sequence analysis. However, their 
molecular masses (1472.4 Da and 2331.6 Da) fit those calcu- 
lated for fragment 31-43 (1472.8 Da) and 31 51 (2330.7 Da) of 
the deduced protein sequence, assuming the N-terminal residue 
to be pyroglutamate. Both residue 44 and 52 are Asp, in accord- 
ance with the specificity of the enzyme. This finding strongly 
indicates that residues 1-30 constitute the signal peptide, as 
predicted by the 'von Heijne rules'[31], and as also suggested 
by [30]. Sequence analysis of the CNBr-treated ProBlott 
showed two sequences which fit residues 6845 and 110-152, 
respectively. From amino acid no. 28 of this analysis, only one 
sequence could be recognized, thus unequivocally identifying 
residues 138 152 of the cDNA deduced sequence to be present 
in p19. Hence, the cDNA cloned by all 3 groups reflects a 
mRNA that is transcribed to a protein stored as an 18-19 kDa 
protein in specific granules of human eutrophils, and that this 
is the major if not the only member of the cathelin family that 
is stored intact in specific granules. We propose that pl 9 should 
be named hCAP- 18. 
The subcellular localization of the proteins belonging to the 
cathelin/pro-bactenecin family has only been determined inbo- 
vine neutrophils. No human correlate of the peroxidase nega- 
tive large granules, the dominating ranule subset of bovine 
neutrophils[32], has been described. This granule subset is the 
store of cationic, bactericidal proteins, like pro-bactenecins 
[19], and contains lactoferrin but lacks lysozyme and vitamin 
Bt2-binding protein [32]. In the human neutrophil, most bacte- 
ricidal cationic proteins are found in azurophil granules [33]. 
The demonstration f hCAP-18 in specific granules of mature 
human neutrophils raises the important questions: how is the 
protein targeted to these granules in the human neutrophil? Is
this protein further processed to generate bactericidal C-termi- 
nal fragments uch as FALL-39 during degranulation? What 
is the interplay between azurophil granules and specific gran- 
ules of human neutrophils in this process? 
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